<style face="normal" font="default" size="100%">The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.</style>

Drupal-Bibcite